Calycosin Enhances Heat Shock Related-Proteins in H9c2 Cells to Modulate Survival and Apoptosis against Heat Shock.

Astragalus Membranaceus Calycosin Cardiomyocyte Heart Protection Heat Shock Heat Shock-Related Protein

Journal

The American journal of Chinese medicine
ISSN: 1793-6853
Titre abrégé: Am J Chin Med
Pays: Singapore
ID NLM: 7901431

Informations de publication

Date de publication:
28 Jun 2024
Historique:
medline: 28 6 2024
pubmed: 28 6 2024
entrez: 28 6 2024
Statut: aheadofprint

Résumé

Heat shock proteins (HSPs), which function as chaperones, are activated in response to various environmental stressors. In addition to their role in diverse aspects of protein production, HSPs protect against harmful protein-related stressors. Calycosin exhibits numerous beneficial properties. This study aims to explore the protective effects of calycosin in the heart under heat shock and determine its underlying mechanism. H9c2 cells, western blot, TUNEL staining, flow cytometry, and immunofluorescence staining were used. The time-dependent effects of heat shock analyzed using western blot revealed increased HSP expression for up to 2[Formula: see text]h, followed by protein degradation after 4[Formula: see text]h. Hence, a heat shock damage duration of 4[Formula: see text]h was chosen for subsequent investigations. Calycosin administered post-heat shock demonstrated dose-dependent recovery of cell viability. Under heat shock conditions, calycosin prevented the apoptosis of H9c2 cells by upregulating HSPs, suppressing p-JNK, enhancing Bcl-2 activation, and inhibiting cleaved caspase 3. Calycosin also inhibited Fas/FasL expression and activated cell survival markers (p-PI3K, p-ERK, p-Akt), indicating their cytoprotective properties through PI3K/Akt activation and JNK inhibition. TUNEL staining and flow cytometry confirmed that calycosin reduced apoptosis. Moreover, calycosin reversed the inhibitory effects of quercetin on HSF1 and Hsp70 expression, illustrating its role in enhancing Hsp70 expression through HSF1 activation during heat shock. Immunofluorescence staining demonstrated HSF1 translocation to the nucleus following calycosin treatment, emphasizing its cytoprotective effects. In conclusion, calycosin exhibits pronounced protective effects against heat shock-induced damages by modulating HSP expression and regulating key signaling pathways to promote cell survival in H9c2 cells.

Identifiants

pubmed: 38938156
doi: 10.1142/S0192415X24500472
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-21

Auteurs

Pei-Fang Lai (PF)

Department of Emergency Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 970, Taiwan.
Department of Medicine, Tzu Chi University, Hualien 970, Taiwan.

Ramasamy Mahendran (R)

Cardiovascular and Mitochondrial Related Disease Research Center, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 970, Taiwan.

Bruce Chi-Kang Tsai (BC)

Cardiovascular and Mitochondrial Related Disease Research Center, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 970, Taiwan.

Cheng-You Lu (CY)

Cardiovascular and Mitochondrial Related Disease Research Center, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 970, Taiwan.
Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung 402, Taiwan.

Chia-Hua Kuo (CH)

Laboratory of Exercise Biochemistry, University of Taipei, Taipei 111, Taiwan.
Institute of Sports Sciences, University of Taipei, Taipei 111, Taiwan.
School of Physical Education and Sports Science, Soochow University, Suzhou 215021, China.
Department of Kinesiology and Health, College of William and Mary, Williamsburg, VA 23185, USA.

Kuan-Ho Lin (KH)

Department of Emergency Medicine, China Medical University Hospital, Taichung 404, Taiwan.
College of Medicine, China Medical University, Taichung 406, Taiwan.

Shang-Yeh Lu (SY)

College of Medicine, China Medical University, Taichung 406, Taiwan.
Division of Cardiovascular Medicine, Department of Internal, Medicine China Medical University Hospital, Taichung 404, Taiwan.

Yu-Ling Wu (YL)

Cardiovascular and Mitochondrial Related Disease Research Center, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 970, Taiwan.

Yung-Ming Chang (YM)

The School of Chinese Medicine for Post-Baccalaureate, I-Shou University, 840, Kaohsiung, Taiwan.
Chinese Medicine Department, E-DA Hospital, Kaohsiung, 824, Taiwan.
1PT Biotechnology Co., Ltd., Taichung 433, Taiwan.

Wei-Wen Kuo (WW)

Department of Biological Science and Technology, College of Life Sciences, China Medical University, Taichung 406, Taiwan.
Ph.D. Program for Biotechnology Industry, China Medical University, Taichung 406, Taiwan.
School of Pharmacy, China Medical University, Taichung 406, Taiwan.

Chih-Yang Huang (CY)

Cardiovascular and Mitochondrial Related Disease Research Center, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 970, Taiwan.
Graduate Institute of Biomedical Sciences, China Medical University, Taichung 406, Taiwan.
Department of Medical Laboratory Science and Biotechnology, Asia University, Taichung 413, Taiwan.
Center of General Education, Buddhist Tzu Chi Medical Foundation, Tzu Chi University of Science and Technology, Hualien 970, Taiwan.
Department of Medical Research, China Medical University Hospital, China Medical University, Taichung 404, Taiwan.

Classifications MeSH